Table 1.
Demographic information.
Demographics | Total | Not admitted to ICU | Admitted to ICU | p-Value | Alive | Dead | p-value |
---|---|---|---|---|---|---|---|
N | 1096 | 1054 (96.2%) | 42 (3.8%) | 1077 (98.3%) | 19 (1.7%) | ||
Age (years), median (IQR) [range] | 41 (25–75) [0–93] | 37.1 ± 16 | 54.8 ± 11 | p<0.000 | 38.7 ± 15.1 | 55.0 ± 10.1 | p<0.000 |
0–14 years | 33 (3.0%) | ||||||
15–49 years | 752 (68.6%) | ||||||
50–64 years | 231 (21.1%) | ||||||
≥ 65 years | 80 (7.3%) | ||||||
Gender | 0.422 | 1.000 | |||||
Female | 208 (19.0%) | 198 (95.2%) | 10 (4.8%) | 205 (98.6%) | 3 (1.4%) | ||
Male | 888 (81.0%) | 856 (96.4%) | 32 (3.6%) | 872 (98.2%) | 16 (1.8%) | ||
Body Mass Index WHO criteria BMI, above age 12 years old (%) Underweight (<18.5) Normal (18.5 −24.9) Overweight (25–29.9) Obese (≥ 30) |
26.6 ± 4.6 11 (1.6%) 236 (35.0%) 280 (41.5%) 147 (21.8%) |
26.8 ± 7.7 | 29.0 ± 5.1 | p<0.000 | 26.8 ± 5.9 | 33.0 ± 4.7 | p<0.000 |
Smoker | 44 (4.0%) | 39 (88.6%) | 5 (11.4%) | p<0.023 | 42 (95.5%) | 2 (4.5%) | 0.175 |
Nationality | p<0.001 | 0.060 | |||||
Bangladesh | 70 (6.4%) | 66 (94.3%) | 4 (5.7%) | 68 (97.1%) | 2 (2.9%) | ||
Egypt | 72 (6.6%) | 3 (4.2%) | 72 (100.0%) | 0 (0.0%) | |||
India | 527 | 69 (95.8%) | 6 (1.1%) | 4 (0.8%) | |||
Iran | (48.1%) | 2 (8.7%) | 523 (99.2%) | 2 (8.7%) | |||
Kuwait | 23 (2.1%) | 521 | 22 (7.4%) | 9 (3.0%) | |||
Philippines | 297 | (98.9%) | 0 (0.0%) | 21 (91.3%) | 0 (0%) | ||
European | (27.1%) | 21 (91.3%) | 0(0.0%) | 288 (97.0%) | 0 (0.0%) | ||
Other | 20 (1.8%) | 5 (6.3%) | 2 (2.5%) | ||||
4 (0.4%) | 275 | 20 (100.0%) | |||||
80 (7.3%) | (92.6%) | ||||||
20 (100.0%) | 4 (100%) | ||||||
4 (100.0%) | 78 (97.5%) | ||||||
75 (93.8%) | |||||||
Travel History | p<0.001 | p<0.000 | |||||
Iran | 79 (7.2%) | 72 (91.1%) | 7 (8.9%) | 79 (100.0%) | 0 (0.0%) | 0.214 | |
United Kingdom | 84 (7.7%) | 2 (2.4%) | p<0.019 | 2 (2.4%) | 0.771 | ||
Other (Europe) | 19 (1.7%) | 82 (97.6%) | 0 (0.0%) | 82 (97.6%) | 0 (0.0%) | 0.427 | |
France | 13 (1.2%) | 1 (7.7%) | 0.359 | 19 (100.0%) | 1 (7.7%) | 0.210 | |
Other (Asia) | 24 (2.2%) | 19 | 1 (4.2%) | 0.294 | 0 (0.0%) | 0.496 | |
Other (Africa) | 11 (1.0%) | (100.0%) | 1 (9.1%) | 0.701 | 12 (92.3%) | 0 (0.0%) | 0.658 |
United States of America | 6 (0.5%) | 12 (92.3%) | (0.0%) | 0.412 | 24 (100.0%) | 0 (0.0%) | ⁎⁎⁎ |
Other (S. America) | 2 (0.2%) | 0 (0.0%) | 0.361 | 0 (0.0%) | ⁎⁎⁎ | ||
Saudi Arabia | 4 (0.4%) | 23 (95.8%) | 1 (25.0%) | ⁎⁎⁎ | 11 (100.0%) | 0 (0.0%) | ⁎⁎⁎ |
Italy | 1 (0.1%) | 0 (0.0%) | ⁎⁎⁎ | 0 (0.0%) | ⁎⁎⁎ | ||
Spain | 3 (0.3%) | 10 (90.9%) | |||||
China | 2 (0.2%) | 6 (100.0%) | |||||
Multiple | 18 (1.6%) | 2 (100.0%) | |||||
None | 830 (75.7%) | 3 (75.0%) | |||||
1 (100.0%) | |||||||
3 (100.0%) | |||||||
1 (50.0%) | |||||||
17 (94.4%) | |||||||
803 (96.7%) | |||||||
0 (0.0%) | ⁎⁎⁎ | 6 (100.0%) | 0 (0.0%) | ⁎⁎⁎ | |||
1 (50.5%) | ⁎⁎⁎ | 2 (100.0%) | 1 (50.0%) | ⁎⁎⁎ | |||
1 (5.6%) | ⁎⁎⁎ | 4 (100.0%) | 1 (5.6%) | ⁎⁎⁎ | |||
27 (3.3%) | ⁎⁎⁎ | 1 (100.0%) | 14 (1.7%) | 0.834 | |||
0.078 | 3 (100.0%) | ||||||
1 (50.0%) | |||||||
17 (94.4%) | |||||||
816 (98.3%) | |||||||
Transmission source | p < 0.033 | p < 0.028 | |||||
Unknown | 313 | 297 (94.9%) | 16 (5.1%) | 302 (96.5%) | 11 (3.5%) | ||
Contact | 518 | 518 (97.9%) | 11 (2.1%) | 4 (0.8%) | |||
Travel | 238 | 224 (94.1%) | 14 (5.9%) | 525 (99.2%) | 4 (1.7%) | ||
Healthcare worker | 16 | 15 (93.8%) | 1 (6.3%) | 0 (0.0%) | |||
234 (98.3%) | |||||||
16 (100.0%) |
Reduced power due to small sample size (<10).